Testmate Health

Testmate Health

Private
LausanneHealthcare & Life Scienceshttps://www.testmatehealth.com/

Last Round

Seed

May 8, 2024

Total Funding Raised

$7.74M

Momentum Score

25 /100

Company Overview

Testmate Health is a medtech company that develops rapid at-home self-testing kits for sexually transmitted infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Telemedicine

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

at-home STI testSTI self-testmedtechrapid diagnosticsmolecular diagnosticshealthtechover-the-counter testOTC testsexual wellnessurine-based testmedical devicedigital health apptelemedicinedirect-to-consumerD2Cconnected diagnosticspublic health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Testmate Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Testmate Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMay 8, 2024
Pre SeedOct 27, 2021

Key People

Founding team and executive leadership

Kelly Lewis Brezoczky

Chief Operating Officer Interim CEO Advisor

Executive Team

Siew-Veena Sahi

CEO & Co-Founder

Founding Team

Testmate Health Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 16, 2025

    Grew 30% QoQ from 10 to 13 employees.

  • Oct 30, 2024

    Monthly visitors increased 142% MoM.

Testmate Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Testmate Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Testmate Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range13
Year Founded2020
Last FundingMay 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.